$Venetoclax alone or in combination with other regimens treatment achieve deep and sustained remission of relapsed/refractory chronic lymphocytic leukemia: a meta-analysis$

Venetoclax alone or in combination with other regimens treatment achieve deep and sustained remission of relapsed/refractory chronic lymphocytic leukemia: a meta-analysis

Recently, the use of novel targeted drugs significantly improved the overall response rate (ORR) and survival of patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL). The treatment of R/R CLL has been gradually developed from traditional chemotherapy to targeted therapy. Venetocl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental medicine 2022-05, Vol.22 (2), p.161-171
Hauptverfasser:	Tang, Xiao, Zou, Wenrong, Peng, Peng, Bai, Yanglu
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bridged Bicyclo Compounds, Heterocyclic - adverse effects Bridged Bicyclo Compounds, Heterocyclic - therapeutic use CD20 antigen Chemotherapy Chronic lymphocytic leukemia Cytogenetics Hematology Humans Internal Medicine Leukemia Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Medicine Medicine & Public Health Meta-analysis Minimal residual disease Monoclonal antibodies Oncology Patients Recurrence Remission Remission (Medicine) Review Article Sulfonamides - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!